CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-06 | Colangelo Dominick President and CEO | Option exercise · Restricted Stock Unit | −6,938 | $47.18 | $327K | 13,875 |
| 2021-01-25 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,832 | 150,832 | ||
| 2021-01-25 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Restricted Stock Unit | +16,000 | 16,000 | ||
| 2021-01-25 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Stock Option (right to buy) | +9,168 | 9,168 | ||
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +5,000 | $10.95 | $55K | 9,331 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Sale | −5,000 | $26.27 | $131K | 4,331 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +18,264 | $10.95 | $200K | 22,595 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Sale | −7,526 | $26.61 | $200K | 15,069 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +20,000 | $10.95 | $219K | 35,069 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Sale | −11,709 | $26.61 | $312K | 23,360 |
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,000 | 130,000 | ||
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −20,000 | 110,000 | ||
| 2020-12-21 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −18,264 | 91,736 | ||
| 2020-12-21 | Halpin Michael Chief Operating Officer | Option exercise | +30,000 | $2.65 | $80K | 32,279 |
| 2020-12-21 | Halpin Michael Chief Operating Officer | Sale | −30,000 | $26.28 | $788K | 2,279 |
| 2020-12-21 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (right to buy) | −30,000 | 47,063 | ||
| 2020-11-23 | ZERBE ROBERT L MD Director | Option exercise | +15,000 | $3.74 | $56K | 34,295 |
| 2020-11-23 | ZERBE ROBERT L MD Director | Option exercise | +15,000 | $2.76 | $41K | 49,295 |
| 2020-11-23 | ZERBE ROBERT L MD Director | Sale | −17,500 | $23.55 | $412K | 31,795 |
| 2020-11-23 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 |
Page 53 of 75 · 1,497 trades